A.N.M. Wymenga - Concepedia

Author

A.N.M. Wymenga

Also Known As

A N M Wymenga, A N Machteld Wymenga, A N Wymenga, A Wymenga, A. N. M. Wymenga, A. N. Machteld Wymenga, A. Wymenga, A.N. Machteld Wymenga, A.N. Wymenga, A.N.M. Wymenga

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Medisch Spectrum Twente University Medical Center Groningen University of Groningen The Netherlands Cancer Institute Radboud University Nijmegen

About

A.N.M. Wymenga is an author at Medisch Spectrum Twente specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	791
2	Health Sciences	2	2	114
3	Nursing	1	1	133
4	Allergy	1	1	57
5	Athletic Training	1	1	57

A.N.M. Wymenga

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and Safety of Prolonged-Release Lanreotide in Patients With Gastrointestinal Neuroendocrine Tumors and Hormone-Related Symptoms A.N.M. Wymenga, Barbro Eriksson, Pasi Salmela, Journal of Clinical Oncology	1999	223
Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group Marije E. Hamaker, Caroline Seynaeve, A.N.M. Wymenga, The Breast NursingGeriatric OncologyOncologyAgingBreast Oncology	2013	133
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III study Bonne Biesma, A.N.M. Wymenga, Andrew Vincent, Annals of Oncology Geriatric OncologyElderly PatientsGeriatricsMedicineCancer Management	2011	100
Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study Ciska Buijs, Constantijne H. Mom, Pax H.B. Willemse, Breast Cancer Research and Treatment Breast OncologyBreast Cancer PatientsMedicinePharmacologyBreast Cancer	2008	89
A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG Carolien H. Smorenburg, S.M. de Groot, A. Elise van Leeuwen‐Stok, Annals of Oncology Breast OncologyOncologyElderly PatientsOmega StudyMedicine	2014	60
Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumours Anouk N.A. van der Horst‐Schrivers, Wendy J. Post, Ido P. Kema, European Journal of Cancer UrologySurgical OncologyGastrointestinal OncologyGenitourinary CancerMedicine	2007	60
Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis. A.N.M. Wymenga, W T van der Graaf, L.S. Hofstra, PubMed ImmunologyOral MicrobiologyOral MedicineGrowth Factor-beta3 MouthwashesSalivary Gland	1999	57
The value of routine follow‐up in patients treated for carcinoma of the vulva Maaike H.M. Oonk, Joanne A. de Hullu, Harry Hollema, Cancer	2003	57
The effects of prehabilitation versus usual care to reduce postoperative complications in high-risk patients with colorectal cancer or dysplasia scheduled for elective colorectal resection: study protocol of a randomized controlled trial Annefleur E.M. Berkel, Bart C. Bongers, Marie-Janne S. van Kamp, BMC Gastroenterology Surgical OncologyPhysical ActivityColorectal SurgerySurgeryExercise Oncology	2018	57
Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma S.A.M. van de Schans, A.N.M. Wymenga, D.J. van Spronsen, Annals of Oncology Hematological MalignancyLymphoid NeoplasiaElderly PatientsMedicineStandard Chemotherapy	2011	44

Page 1